Morgan Stanley Tiziana Life Sciences LTD Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Morgan Stanley holds 110,831 shares of TLSA stock, worth $87,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,831
Previous 109,747
0.99%
Holding current value
$87,556
Previous $105,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding TLSA
# of Institutions
30Shares Held
1.04MCall Options Held
19.2KPut Options Held
0-
Geode Capital Management, LLC Boston, MA246KShares$194,1200.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$83,2380.0% of portfolio
-
Zhang Financial LLC93.2KShares$73,6170.0% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$62,6980.0% of portfolio
-
Ewa, LLC Pittsbugh, PA50.1KShares$39,5850.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $80.8M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...